Sana Biotechnology, Inc.
SANA
$1.76
-$0.01-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 44.31% | -6,189.84% | 55.88% | -30.87% | -9.54% |
| Total Depreciation and Amortization | -10.54% | -9.82% | -12.43% | -13.81% | 1.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -128.46% | 105.92% | -139.44% | 389.24% | 275.52% |
| Change in Net Operating Assets | -58.31% | -106.64% | -83.22% | 30.96% | 283.32% |
| Cash from Operations | 9.23% | 18.46% | 0.44% | 17.21% | 31.69% |
| Capital Expenditure | 96.90% | -83.30% | -727.90% | -628.17% | -205.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.89% | -14.40% | -57.30% | -194.58% | -68.44% |
| Cash from Investing | 207.56% | -18.64% | -86.35% | -223.12% | -82.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.31% | 921.39% | -89.84% | 78,881.78% | 61.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -62.57% | 1,013.37% | -63.98% | 78,881.78% | 61.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.63% | 33.73% | -415.78% | 366.95% | -360.25% |